Abstract
Traumatic brain injury (TBI) is associated with life-threatening and permanent disabilities. Given the limited capacity of neurons to regenerate, effective treatments for TBI are lacking. Neural stem cells (NSCs) can differentiate into fully functioning neurons and thus hold promise for TBI treatment. Nonetheless, NSC differentiation and proliferation are slow and inefficient. Studies have shown that piezoelectric stimulation is capable of promoting the differentiation and proliferation of NSCs. Here, we describe barium titanate–reduced graphene oxide (BTO/rGO) hybrid piezoelectric nanostickers that promote NSC proliferation and differentiation. These hybrid nanostickers attach to NSC membranes, serving as long-term generators of piezoelectric potentials upon ultrasound stimulation. BTO/rGO nanostickers promote rapid neuronal differentiation and maturation by activating the voltage-gated calcium channel/Ca2+/calmodulin-dependent protein kinase II/cAMP response element-binding protein pathways. Transplantation of NSCs with BTO/rGO nanostickers into the injured brain region of rats with TBI substantially repairs brain tissue and effectively restores physiological functions after 28 d following 5-min ultrasound irradiation every 2 d. These results demonstrate the potential of the combination of NSCs and BTO/rGO nanostickers for TBI treatment.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
The data that support the findings are available within the main text and the Supplementary Information and can be obtained from the corresponding authors upon request. The RNA-Seq experiment data are available in the Gene Expression Omnibus (GEO) with the accession code GSE285483 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi). Source data are provided with this paper.
References
Roth, T. L. et al. Transcranial amelioration of inflammation and cell death after brain injury. Nature 505, 223–228 (2014).
Villapol, S., Balarezo, M. G., Affram, K., Saavedra, J. M. & Symes, A. J. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain 138, 3299–3315 (2015).
Jamjoom, A. A. B., Rhodes, J., Andrews, P. J. D. & Grant, S. G. N. The synapse in traumatic brain injury. Brain 144, 18–31 (2021).
Empl, L. et al. Selective plasticity of callosal neurons in the adult contralesional cortex following murine traumatic brain injury. Nat. Commun. 13, 2659 (2022).
Ruddy, R. M., Adams, K. V. & Morshead, C. M. Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke. Sci. Adv. 5, eaax1912 (2019).
Luo, Y. et al. Single-cell transcriptome analyses reveal signals to activate dormant neural stem cells. Cell 161, 1175–1186 (2015).
Ziegler, A. N., Levison, S. W. & Wood, T. L. Insulin and IGF receptor signalling in neural-stem-cell homeostasis. Nat. Rev. Endocrinol. 11, 161–170 (2015).
Mercier, F. Fractones: extracellular matrix niche controlling stem cell fate and growth factor activity in the brain in health and disease. Cell. Mol. Life Sci. 73, 4661–4674 (2016).
Hao, M. et al. Hydroxyapatite nanorods function as safe and effective growth factors regulating neural differentiation and neuron development. Adv. Mater. 33, e2100895 (2021).
Kong, Y. et al. Regulation of stem cell fate using nanostructure-mediated physical signals. Chem. Soc. Rev. 50, 12828–12872 (2021).
He, L. et al. Electrical stimulation at nanoscale topography boosts neural stem cell neurogenesis through the enhancement of autophagy signaling. Biomaterials 268, 120585 (2021).
Liu, Z., Wan, X., Wang, Z. L. & Li, L. Electroactive biomaterials and systems for cell fate determination and tissue regeneration: design and applications. Adv. Mater. 33, e2007429 (2021).
Yang, H. et al. Gold nanostrip array-mediated wireless electrical stimulation for accelerating functional neuronal differentiation. Adv. Sci. 9, e2202376 (2022).
Lai, B. Q. et al. Stem cell-derived neuronal relay strategies and functional electrical stimulation for treatment of spinal cord injury. Biomaterials 279, 121211 (2021).
Xiao, C. et al. One-dimensional ferroelectric nanoarrays with wireless switchable static and dynamic electrical stimulation for selective regulating osteogenesis and antiosteosarcoma. ACS Nano 16, 20770–20785 (2022).
Grill, W. M., Norman, S. E. & Bellamkonda, R. V. Implanted neural interfaces: biochallenges and engineered solutions. Annu. Rev. Biomed. Eng. 11, 1–24 (2009).
Zitnik, R. J. Treatment of chronic inflammatory diseases with implantable medical devices. Ann. Rheum. Dis. 70, i67–i70 (2011).
Marino, A. et al. Piezoelectric barium titanate nanostimulators for the treatment of glioblastoma multiforme. J. Colloid Interface Sci. 538, 449–461 (2019).
Pucci, C. et al. Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells. Acta Biomater. 139, 218–236 (2022).
Ciofani, G. et al. Enhancement of neurite outgrowth in neuronal-like cells following boron nitride nanotube-mediated stimulation. ACS Nano 4, 6267–6277 (2010).
Hoop, M. et al. Ultrasound-mediated piezoelectric differentiation of neuron-like PC12 cells on PVDF membranes. Sci. Rep. 7, 4028 (2017).
Wei, M., Li, S. & Le, W. Nanomaterials modulate stem cell differentiation: biological interaction and underlying mechanisms. J. Nanobiotechnology 15, 75 (2017).
Zhu, P., Chen, Y. & Shi, J. Piezocatalytic tumor therapy by ultrasound-triggered and BaTiO3-mediated piezoelectricity. Adv. Mater. 32, e2001976 (2020).
Jiang, B. et al. Barium titanate at the nanoscale: controlled synthesis and dielectric and ferroelectric properties. Chem. Soc. Rev. 48, 1194–1228 (2019).
Zhao, D. et al. Electromagnetized-nanoparticle-modulated neural plasticity and recovery of degenerative dopaminergic neurons in the mid-brain. Adv. Mater. 32, e2003800 (2020).
Marino, A. et al. Piezoelectric nanoparticle-assisted wireless neuronal stimulation. ACS Nano 9, 7678–7689 (2015).
Arhem, P. Voltage sensing in ion channels: a 50-year-old mystery resolved? Lancet 363, 1221–1223 (2004).
Li, H. et al. Enhanced ferroelectric-nanocrystal-based hybrid photocatalysis by ultrasonic-wave-generated piezophototronic effect. Nano Lett. 15, 2372–2379 (2015).
Khacho, M., Harris, R. & Slack, R. S. Mitochondria as central regulators of neural stem cell fate and cognitive function. Nat. Rev. Neurosci. 20, 34–48 (2019).
Shen, Y. et al. Biomaterial cues regulated differentiation of neural stem cells into GABAergic neurons through Ca2+/c-Jun/TLX3 signaling promoted by hydroxyapatite nanorods. Nano Lett. 21, 7371–7378 (2021).
Schley, N. D. et al. Distinguishing homogeneous from heterogeneous catalysis in electrode-driven water oxidation with molecular iridium complexes. J. Am. Chem. Soc. 133, 10473–10481 (2011).
Selvaraj, P., Tanaka, M., Wen, J. & Zhang, Y. The novel monoacylglycerol lipase inhibitor MJN110 suppresses neuroinflammation, normalizes synaptic composition and improves behavioral performance in the repetitive traumatic brain injury mouse model. Cells 10, 3454 (2021).
Wang, C. S., McCarthy, C. I., Guzikowski, N. J., Kavalali, E. T. & Monteggia, L. M. Brain-derived neurotrophic factor scales presynaptic calcium transients to modulate excitatory neurotransmission. Proc. Natl Acad. Sci. USA 121, e2303664121 (2024).
Zhu, J. et al. The mechanosensitive ion channel Piezo1 contributes to ultrasound neuromodulation. Proc. Natl Acad. Sci. USA 120, e2300291120 (2023).
Kollewe, A. et al. Subunit composition, molecular environment, and activation of native TRPC channels encoded by their interactomes. Neuron 110, 4162–4175 e4167 (2022).
Maier, L. S. & Bers, D. M. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation–contraction coupling in the heart. Cardiovasc. Res. 73, 631–640 (2007).
Kong, G. et al. AMPK controls the axonal regenerative ability of dorsal root ganglia sensory neurons after spinal cord injury. Nat. Metab. 2, 918–933 (2020).
Carlezon, W. A. Jr., Duman, R. S. & Nestler, E. J. The many faces of CREB. Trends Neurosci. 28, 436–445 (2005).
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U. & Patel, N. K. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol. Ther. 138, 155–175 (2013).
Wang, Z. et al. The neuroprotective mechanism of sevoflurane in rats with traumatic brain injury via FGF2. J. Neuroinflammation 19, 51 (2022).
Chen, J. et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005–1011 (2001).
Tian, X. et al. NeuN-specific fluorescent probe revealing neuronal nuclei protein and nuclear acids association in living neurons under STED nanoscopy. ACS Appl. Mater. Interfaces 10, 31959–31964 (2018).
Aboody, K., Capela, A., Niazi, N., Stern, J. H. & Temple, S. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone. Neuron 70, 597–613 (2011).
Miao, P. et al. Graphene nanostructure-based tactile sensors for electronic skin applications. Nanomicro Lett. 11, 71 (2019).
Wu, J. et al. Insights into the role of ferroelectric polarization in piezocatalysis of nanocrystalline BaTiO3. ACS Appl. Mater. Interfaces 10, 17842–17849 (2018).
Gu, W. et al. Palladium cubes with Pt shell deposition for localized surface plasmon resonance enhanced photodynamic and photothermal therapy of hypoxic tumors. Biomater. Sci. 10, 216–226 (2021).
Thomas, H. R., Marsden, A. J., Walker, M., Wilson, N. R. & Rourke, J. P. Sulfur-functionalized graphene oxide by epoxide ring-opening. Angew. Chem. Int Ed. Engl. 53, 7613–7618 (2014).
Welkenhuysen, M. et al. An integrated multi-electrode-optrode array for in vitro optogenetics. Sci. Rep. 6, 20353 (2016).
Martinez, A. L. et al. Identification of sodium transients through NaV1.5 channels as regulators of differentiation in immortalized dorsal root ganglia neurons. Front Cell Neurosci. 16, 816325 (2022).
Pan, M. X. et al. Sex-dependent effects of GPER activation on neuroinflammation in a rat model of traumatic brain injury. Brain Behav. Immun. 88, 421–431 (2020).
Lee, J. Y. et al. Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model. Theranostics 9, 1029–1046 (2019).
Bae, M. et al. Neural stem cell delivery using brain-derived tissue-specific bioink for recovering from traumatic brain injury. Biofabrication 13, 044110 (2021).
Acknowledgements
We would like to thank the STI 2030-Major Projects (2021ZD0201600 (H.L.)), the National Natural Science Foundation of China (T2321004 (F.Y.), 52202351 (J.Q.), 82273195 (G.L.), 82072776 (G.L.)), the Natural Science Foundation of Shandong Province (ZR2022ZD20 (J.Q.), 2022HWYQ-052 (J.Q.), ZR2021LSW025 (G.L.)), the Fundamental Research Funds for the Central Universities (2022JC019 (J.Q.)) and the Taishan Scholarship in Shandong Provinces (tspd20210322 (G.L.), tsqn20221102 (J.Q.)) for the support of our work.
Author information
Authors and Affiliations
Contributions
H.L., W.W. and J.Q. conceived and designed the experiments. W.W. and K.L. performed the experiments and made analyses; W.M. and Y.L. assisted in conducting animal experiments. F.L., Y.K. and L.W. participated in the discussion. Y.S., F.Y., G.L., J.Q. and H.L. provided the contributed reagents/materials/analysis tools. W.W. and K.L. wrote the manuscript with inputs from all authors.
Corresponding authors
Ethics declarations
Competing interests
J.Q., W.W., K.L., W.M., Y.L., L.W., Y.S. and H.L. have filed a patent (Piezoelectric composite nanostickers for regulation of the differentiation of neural stem cells) related to this paper. F.L., Y.K., F.Y. and G.L. declare no competing interests.
Peer review
Peer review information
Nature Materials thanks Xiangzhong Chen, Gianni Ciofani and Jin Nam for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Schematic of the effects of BTO/rGO nanostickers in vitro and in vivo.
(a) BTO/rGO nanostickers facilitated the differentiation of NSCs into functional neurons and prevented damage by ROS during ultrasound treatment. (b) The application of BTO/rGO nanostickers in NSC-based therapy for TBI. Figure elements have been created with Figdraw.com.
Extended Data Fig. 2 Influence of BTO nanoparticles on NSCs and PC12 cells under ultrasound irradiation.
(a–b) mRNA levels of Tuj1 and MAP2 in NSCs after 5 days. (c) Western blot of Tuj1 and MAP2 levels in NSCs after 5 days and (d) associated analyses. (e–f) mRNA levels of Tuj1 and MAP2 in PC12 cells after 5 days. (g) Western blot of Tuj1 and MAP2 levels in PC12 cells after 5 days and (h) associated analyses. (i) Images from the live/dead assay (green: live cell; red: dead cell) and (j) analysis of the survival rate of NSCs after 3 days. (k) Images from the live/dead assay (green: live cell; red: dead cell) and (l) analysis of the survival rate of PC12 cells after 3 days. (m) CCK-8 assay results for NSCs. (n) CCK-8 assay results for PC12 cells. (o) EdU proliferation assay results for NSCs (green: proliferating cells; blue: Hoechst). (p) The proliferation ability of NSCs was assessed via the EdU proliferation assay. (q) EdU proliferation assay results for PC12 cells (green: proliferating cells; blue: Hoechst). (r) The proliferation ability of PC12 cells was assessed via the EdU proliferation assay. The data in a, b, d-f, h, j, l-n, p and r are shown as mean ± s.d., n = 3 independent biological samples for a, b, d-f, h, j, l, p and r; n = 5 independent biological samples for the data in m and n. Statistical analyses were performed via one-way ANOVA with Dunnett’s multiple comparisons tests (NS: not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
Extended Data Fig. 3 Comparison of tolerance for ROS between NSCs and PC12 cells.
(a) ROS levels in NSCs after different treatments. (b) Statistical analysis of ROS levels in NSCs. (c) ROS levels in PC12 cells after different treatments. (d) Statistical analysis of ROS levels in PC12 cells. (e) Images from the live/dead assay of NSCs after incubation with various concentrations of H2O2 for 3 days (green: live cells; red: dead cells). (f) Survival rate of NSCs incubated with various concentrations of H2O2 for 3 days. (g) Images from the live/dead assay of PC12 cells after incubation with various concentrations of H2O2 for 3 days (green: live cells; red: dead cells). (h) Survival rate of PC12 cells incubated with various concentrations of H2O2 for 3 days. The data in b, d, f and h are shown as mean ± s.d., n = 3 independent biological samples. Statistical analyses were performed via one-way ANOVA with Dunnett’s multiple comparisons tests (NS: not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
Extended Data Fig. 4 Changes in the membrane potential of NSCs upon treatment with ultrasound-activated BTO/rGO nanostickers.
(a) Schematic showing the measurement of changes in the membrane potential of NSCs upon stimulation with BTO/rGO nanostickers under ultrasound irradiation through MEA. (b) Representative optical image of an NSC adhered to the MEA electrode. A BTO/rGO nanosticker is attached to the NSC. (c) Electrical signal generated by the NSC adhered to the MEA electrode under ultrasound irradiation. The arrow indicates the moment of time when the ultrasound was applied. (d) Signal generated by the NSC with the BTO/rGO nanosticker attached under ultrasound irradiation. The right is enlarged figure of partial signal. The arrow indicates the moment of time when the ultrasound was applied. (e) Schematic showing the examination of the membrane potential of NSCs through a fast-response cell membrane potential probe. (f) Representative fluorescence images of the membrane potential in the NSC group and the corresponding change in fluorescence intensity. (g) Representative fluorescence images of the membrane potential in the NSC + US group and the corresponding change in fluorescence intensity. (h) Representative fluorescence images of the membrane potential in the NSC + BTO/rGO+US group and the corresponding change in fluorescence intensity; the inset shows the fluorescence signal between 22 s and 24 s. The micrographs in f, g and h were obtained from three independent experiments. Figure elements in a,e have been created with Figdraw.com.
Extended Data Fig. 5 Production efficiency of intracellular and extracellular ROS and their influence on NSCs.
(a) Measurement of ROS levels in NSCs after incubation with BTO nanoparticles and treatment with ultrasound at different powers and (b) associated analysis of the ROS level data. (c) ROS levels in NSCs after incubation with BTO/rGO nanostickers and treatment with ultrasound at different powers and (d) associated analysis of the ROS level data. (e) Images from the live/dead assay and (f) analysis of the survival rate of NSCs after incubation with BTO nanoparticles and treatment with ultrasound at different powers (green: live cells; red: dead cells). (g) Images from the live/dead assay and (h) analysis of the survival rate of NSCs after incubation with BTO/rGO nanostickers and treatment with ultrasound at different powers (green: live cells; red: dead cells). (i–j) mRNA levels of Tuj1 and MAP2 in NSCs that were incubated with BTO nanoparticles and treated with ultrasound at different powers. (k–l) mRNA levels of Tuj1 and MAP2 in NSCs that were incubated with BTO/rGO nanostickers and treated with ultrasound at different powers. The data in b, d, f, and h-l are shown as mean ± s.d., n = 3 independent biological samples. Statistical analyses were performed via one-way ANOVA with Dunnett’s multiple comparisons tests (NS: not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).
Extended Data Fig. 6 Differences in genes expression and gene enrichment analysis.
(a) Volcanic map of differentially expressed genes (BTO/rGO+US group vs. TCP group) (DEGs: differentially expressed genes; red dots: upregulated genes; green dots: downregulated genes). (b) Heatmap of gene expression among the four groups. (c) KEGG pathway enrichment analysis of the differentially expressed genes (BTO/rGO+US group vs. TCP group). (d) GO enrichment analysis (biological process terms) of the differentially expressed genes (BTO/rGO+US group vs. TCP group). (e) GO enrichment analysis (cellular component terms) of the differentially expressed genes (BTO/rGO+US group vs. TCP group). (f) GO enrichment analysis (molecular function terms) of the differentially expressed genes (BTO/rGO+US group vs. TCP group).
Extended Data Fig. 7 P-KN93 inhibits intracellular signal transduction induced by BTO/rGO + US treatment.
(a) Schematic of intracellular signal transduction after P-KN93 treatment. (b) Western blot data derived from three independent experiments and (c) associated analyses of Tuj1 and MAP2 levels in NSCs treated with or without P-KN93. (d) Western blot data derived from three independent experiments and (e) associated analysis of P-CREB, CREB and BDNF levels in NSCs treated with or without P-KN93. (f) Immunofluorescence staining for P-CREB in NSCs treated with or without P-KN93 (red: F-actin; green: P-CREB; blue: DAPI). (g) Statistical analysis of the fluorescence intensity of P-CREB. (h) Immunofluorescence staining for BDNF in NSCs treated with or without P-KN93 (red: F-actin; green: BDNF; blue: DAPI). (i) Statistical analysis of the fluorescence intensity of BDNF. (j) Measurement of the amount of BDNF secreted by NSCs treated with or without P-KN93 by ELISA. The data in c, e, g, i and j are shown as mean ± s.d., n = 3 independent biological samples. Statistical analyses were performed via one-way ANOVA with Dunnett’s multiple comparisons tests (NS: not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Figure elements in a have been created with Figdraw.com.
Extended Data Fig. 8 BTO/rGO piezoelectric nanostickers promote the neuronal differentiation of NSCs in vivo.
(a) Schematic of the in vivo experiments. (b) Representative image of surgery for NSC injection. (c) Representative image of the brain after 7 days of treatment. (d–e) Representative images of immunofluorescence images staining Tuj1/GFAP and MAP2/GFAP in brain sections from one of three rats in each group on day 7 (red: GFAP; green: MAP2 or Tuj1; blue: DAPI). (f) mRNA levels of Tuj1 and MAP2 in the four groups. (g) Western blot of Tuj1 and MAP2 levels in the four groups and (h) associated analyses. The data in f and h are shown as mean ± s.d., n = 3 independent biological samples. Statistical analyses were performed via one-way ANOVA with Dunnett’s multiple comparisons tests (NS: not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Figure elements in a have been created with Figdraw.com.
Extended Data Fig. 9 Repair of brain tissue in experimental rats.
(a) Representative images of brains after 28 days of treatment. (b) Representative panoramic scans and locally enlarged images of HE staining in the brains. (c) Representative images of Nissl staining of the brains. (d-f) Representative immunofluorescence images of brain sections from rats that received different treatments for 28 days (green: NeuN, MAP2, and Tuj1; red: red: PKH26-labeled NSCs; blue: DAPI). Each image in b-f is from one of six rats per group.
Supplementary information
Supplementary Information
Legends for Supplementary Videos 1–10, Supplementary Methods, Figs. 1–13, Tables 1–5 and unprocessed blots for Supplementary Figs. 2c and 5b,f.
Supplementary Video 1
Representative video of cell membrane potential in individual NSC incubated with BTO/rGO nanostickers when treated with ultrasound.
Supplementary Video 2
Representative video of cell membrane potential in individual NSC.
Supplementary Video 3
Representative video of cell membrane potential in individual NSC when treated with ultrasound.
Supplementary Video 4
Representative video of calcium imaging in BTO/rGO + US group when stimulated with acetylcholine.
Supplementary Video 5
Representative video of calcium imaging in TCP group when treated with acetylcholine.
Supplementary Video 6
Representative video of calcium imaging in BTO/rGO group when treated with acetylcholine.
Supplementary Video 7
Representative video of calcium imaging in US group when treated with acetylcholine.
Supplementary Video 8
Representative video of calcium imaging in individual NSC incubated with BTO/rGO nanostickers when treated with ultrasound.
Supplementary Video 9
Representative video of calcium imaging in individual NSC.
Supplementary Video 10
Representative video of calcium imaging in individual NSC when treated with ultrasound.
Supplementary Video 11
Representative video of beam balance test in Sham, TBI and TBI + NSCs + BTO/rGO + US group. The video is accelerated by a factor of 4.
Supplementary Data 1
Source Data for Supplementary Fig. 2.
Supplementary Data 2
Source Data for Supplementary Fig. 5.
Source data
Source Data Fig. 1
Statistical source data for Fig. 1.
Source Data Fig. 2
Statistical source data for Fig. 2.
Source Data Fig. 3
Statistical source data for Fig. 3.
Source Data Fig. 4
Statistical source data for Fig. 4.
Source Data Fig. 5
Statistical source data for Fig. 5.
Source Data Fig. 6
Statistical source data for Fig. 6.
Source Data Fig. 1
Unprocessed western blots for Fig. 1.
Source Data Fig. 3
Unprocessed western blots for Fig. 3.
Source Data Fig. 4
Unprocessed western blots for Fig. 4.
Source Data Fig. 5
Unprocessed western blots for Fig. 5.
Source Data Extended Data Fig. 2
Statistical source data for Extended Data Fig. 2.
Source Data Extended Data Fig. 3
Statistical source data for Extended Data Fig. 3.
Source Data Extended Data Fig. 5
Statistical source data for Extended Data Fig. 5.
Source Data Extended Data Fig. 7
Statistical source data for Extended Data Fig. 7.
Source Data Extended Data Fig. 8
Statistical source data for Extended Data Fig. 8.
Source Data Extended Data Fig. 2
Unprocessed western blots for Extended Data Fig. 2.
Source Data Extended Data Fig. 7
Unprocessed western blots for Extended Data Fig. 7.
Source Data Extended Data Fig. 8
Unprocessed western blots for Extended Data Fig. 8.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, W., Li, K., Ma, W. et al. Ultrasound-activated piezoelectric nanostickers for neural stem cell therapy of traumatic brain injury. Nat. Mater. 24, 1137–1150 (2025). https://doi.org/10.1038/s41563-025-02214-w
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41563-025-02214-w